Pfizer sells entire stake in Haleon for $3.24 billion

As part of the deal, Sensodyne’s maker, Haleon, agreed to buy back 44 million shares from Pfizer, its current largest shareholder, while 618 million shares will be sold to institutional investors. The total sale amount represents 7.3% of the issued…








